Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 24 Jun, 01:30 am
Regenxbio Inc. (NASDAQ: RGNX) Surges on Positive Analyst Outlook and FDA Alignment for Gene Therapy Analyst Brian Skorney of Robert W. Baird raised the price target for Regenxbio Inc. to $32.00 , indicating significant upside potential. Regenxbio Inc. has aligned with the FDA for
Apogee Therapeutics (NASDAQ: APGE) is being acquired by AbbVie (NYSE: ABBV) for approximately $10.9 billion , a strategic move aimed at expanding AbbVie's immunology drug portfolio. Analyst firm Craig-Hallum downgraded Apogee Therapeutics stock from a "Buy" to a "Hold" rating, ci
UBS analyst Manav Gupta confirmed a Buy rating for Bloom Energy, setting a price target of $322.00 , reflecting confidence in the company's future. Bloom Energy's solid oxide fuel cell technology is positioned as a critical solution for the escalating electricity demands of artif
CVS Health (NYSE:CVS) is demonstrating strong market momentum, with its stock price nearing its 52-week high, reflecting robust performance. The company is strategically expanding into the GLP-1 medication market, leveraging its extensive network of 9,000 pharmacies and virtual M
Safe Bulkers, Inc. reported robust first-quarter results, significantly surpassing analyst expectations for both earnings per share and revenue. The company demonstrated strong profitability with an official EPS of $0.20 and a net income of $22.20 million . Key financial metrics,
Northland Securities raised its price target for IonQ to $70.00 , indicating a potential upside of 18.70% and reflecting strong analyst confidence in the quantum computing stock . IonQ is actively pursuing commercialization, targeting an operational 256-qubit system and launching
Qualcomm's Market Expansion: The company is diversifying beyond smartphones into high-growth areas like automotive, computing, and artificial intelligence (AI), exemplified by the new Snapdragon C Platform for entry-level PCs. Analyst Price Target Increase: Cantor Fitzgerald rais
Eli Lilly (NYSE:LLY) has become the first healthcare firm to reach a $1 trillion market valuation, primarily driven by its leading position in the weight loss drug market. The company demonstrates strong financial performance, with revenue growth of 55.5% year-over-year and a rai
Apple (NASDAQ: AAPL) received a downgrade from Outperform to Hold by KGI Securities, with a new price target of $315.00 . Despite the downgrade, Apple is leveraging its strong "pricing power" to implement device price hikes, supported by its affluent user base. The stock's daily
Western Digital is a pivotal player in the artificial intelligence (AI) boom, providing essential data storage solutions that have fueled significant stock growth . Despite a remarkable 250% year-to-date stock performance driven by AI data center demand , the company faces valuat
Despite reporting robust fiscal third-quarter results, Accenture's stock experienced a significant single-day drop, driven by investor fears regarding the long-term impact of artificial intelligence (AI) on demand for IT consulting services. Wells Fargo lowered its price target f
Wolfe Research upgraded Kimco Realty to Outperform, signaling strong analyst confidence in the REIT's future performance. Kimco Realty has demonstrated robust stock performance , with a 27.82% year-to-date increase and projected 5% annual Funds From Operations (FFO) growth. The c
Wells Fargo set a new price target of $212.00 for Diamondback Energy, indicating a potential 15.53% upside . The company anticipates strong financial performance with earnings per share (EPS) projected at $5.73 (an over 114% increase) and revenue of approximately $4.8 billion (a
RBC Capital set a $130.00 price target for ConocoPhillips, suggesting a 20.66% upside despite recent stock declines. The company is investing $9 billion in its Willow project, projected to add $4 billion in annual cash flow by 2029. ConocoPhillips is expanding globally with a new
Investment firm Goldman Sachs (NYSE: GS) initiated coverage on MDA Space (OTC: MDALF) with a Neutral rating, noting the stock price at $33.66 . MDA Space (OTC: MDALF) is set to acquire Blue Canyon Technologies (BCT) from RTX (NYSE: RTX) for approximately US$620 million , aiming t
Space Exploration Technologies (NASDAQ:SPCX) Faces Valuation Scrutiny Post-Historic IPO Space Exploration Technologies (NASDAQ:SPCX) made history with its record-breaking IPO and maintains a dominant position in the rocket launch market. KeyBanc initiated a " Sector Weight " rati
Honeywell (NASDAQ: HON) is undergoing a significant restructuring, including the spin-off of its Aerospace division. The spin-off aims to create two focused companies, Honeywell Aerospace and Honeywell Technologies, to enhance shareholder value. Following the spin-off, Honeywell
Roth Capital upgraded SM Energy (NYSE:SM) to a Buy rating with a $32.00 price target, suggesting a 17.91% upside. Despite recent stock declines, SM Energy anticipates significant growth, with EPS projected to increase by nearly 25% and revenue by over 158% . While GuruFocus estim
Headlines provided by Investing.com